TXG – 10x Genomics, Inc.
10x Genomics, Inc.TXG
$8.01Name : 10x Genomics, Inc.
Sector : Healthcare
Industry: Health Information Services
Mark. Cap: $979,639,040.00
EPSttm : -1.52
10x Genomics, Inc.
$8.01
4.03%$0.31Float Short %
11.96
Margin Of Safety %
Put/Call OI Ratio
0.37
EPS Next Q Diff
0.26
EPS Last/This Y
0.98
EPS This/Next Y
0.12
Price
8
Target Price
15.23
Analyst Recom
2.4
Performance Q
-48.59
Relative Volume
1.08
Beta
1.92
Ticker: TXG
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-12 | TXG | 10.84 | 0.86 | 0.16 | 12469 |
| 2025-03-13 | TXG | 9.88 | 0.86 | 7.49 | 12484 |
| 2025-03-14 | TXG | 10.35 | 0.86 | 0.07 | 12422 |
| 2025-03-17 | TXG | 10.76 | 0.84 | 1.65 | 12489 |
| 2025-03-18 | TXG | 10.51 | 0.84 | 0.26 | 12484 |
| 2025-03-19 | TXG | 10.3 | 0.84 | 0.16 | 12484 |
| 2025-03-20 | TXG | 9.93 | 0.83 | 0.18 | 12482 |
| 2025-03-21 | TXG | 10.41 | 0.81 | 1.28 | 12598 |
| 2025-03-24 | TXG | 10.38 | 0.40 | 0.16 | 7365 |
| 2025-03-25 | TXG | 9.71 | 0.40 | 0.33 | 7497 |
| 2025-03-26 | TXG | 9.58 | 0.39 | 0.21 | 7478 |
| 2025-03-27 | TXG | 9.42 | 0.38 | 0.31 | 7584 |
| 2025-03-28 | TXG | 9.16 | 0.38 | 0.12 | 7614 |
| 2025-03-31 | TXG | 8.72 | 0.37 | 0.79 | 7702 |
| 2025-04-01 | TXG | 8.66 | 0.37 | 0.86 | 7752 |
| 2025-04-02 | TXG | 8.86 | 0.37 | 0.12 | 7808 |
| 2025-04-03 | TXG | 7.97 | 0.37 | 0.69 | 7832 |
| 2025-04-04 | TXG | 7.46 | 0.36 | 5.04 | 7791 |
| 2025-04-07 | TXG | 7.61 | 0.38 | 0.84 | 7928 |
| 2025-04-08 | TXG | 7.15 | 0.38 | 0.04 | 7945 |
| 2025-04-09 | TXG | 8.68 | 0.37 | 0.19 | 8009 |
| 2025-04-10 | TXG | 7.7 | 0.37 | 0.22 | 8021 |
| 2025-04-11 | TXG | 8 | 0.37 | 0.00 | 8021 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-12 | TXG | 10.83 | -45.4 | -30.5 | -0.54 |
| 2025-03-13 | TXG | 9.88 | -45.4 | -5.6 | -0.54 |
| 2025-03-14 | TXG | 10.34 | -45.4 | -43.0 | -0.54 |
| 2025-03-17 | TXG | 10.76 | -45.4 | -41.1 | -0.54 |
| 2025-03-18 | TXG | 10.51 | -45.4 | -23.5 | -0.54 |
| 2025-03-19 | TXG | 10.29 | -45.4 | -24.2 | -0.54 |
| 2025-03-20 | TXG | 9.95 | -45.4 | -20.8 | -0.54 |
| 2025-03-21 | TXG | 10.41 | -45.4 | -42.7 | -0.54 |
| 2025-03-24 | TXG | 10.39 | -45.4 | -29.6 | -0.54 |
| 2025-03-25 | TXG | 9.75 | -45.4 | -13.0 | -0.54 |
| 2025-03-26 | TXG | 9.58 | -45.4 | -25.0 | -0.54 |
| 2025-03-27 | TXG | 9.41 | -45.4 | -24.9 | -0.54 |
| 2025-03-28 | TXG | 9.16 | -45.4 | -22.3 | -0.54 |
| 2025-03-31 | TXG | 8.73 | -45.4 | -16.5 | -0.54 |
| 2025-04-01 | TXG | 8.67 | -45.4 | -27.9 | -0.54 |
| 2025-04-02 | TXG | 8.85 | -45.4 | -36.1 | -0.54 |
| 2025-04-03 | TXG | 7.97 | -45.4 | -1.0 | -0.54 |
| 2025-04-04 | TXG | 7.46 | -45.4 | -10.4 | -0.54 |
| 2025-04-07 | TXG | 7.60 | -45.4 | -35.9 | -0.54 |
| 2025-04-08 | TXG | 7.14 | -45.4 | -10.6 | -0.54 |
| 2025-04-09 | TXG | 8.67 | -45.4 | -97.7 | -0.54 |
| 2025-04-10 | TXG | 7.70 | -45.4 | 2.9 | -0.54 |
| 2025-04-11 | TXG | 8.00 | -45.4 | -41.9 | -0.54 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-12 | TXG | 0.05 | 1.29 | 13.59 |
| 2025-03-13 | TXG | 0.05 | 1.29 | 13.59 |
| 2025-03-14 | TXG | 0.05 | 1.29 | 13.58 |
| 2025-03-17 | TXG | 0.05 | 1.29 | 13.58 |
| 2025-03-18 | TXG | 0.05 | 1.29 | 13.58 |
| 2025-03-19 | TXG | 0.05 | 1.29 | 13.58 |
| 2025-03-20 | TXG | 0.05 | 1.29 | 13.58 |
| 2025-03-21 | TXG | 0.05 | 1.29 | 13.58 |
| 2025-03-24 | TXG | 0.05 | 1.30 | 13.58 |
| 2025-03-25 | TXG | 0.05 | 1.30 | 13.66 |
| 2025-03-26 | TXG | 0.05 | 1.30 | 11.98 |
| 2025-03-27 | TXG | 0.05 | 1.30 | 11.98 |
| 2025-03-28 | TXG | 0.05 | 1.30 | 11.98 |
| 2025-03-31 | TXG | 0.05 | 1.38 | 11.98 |
| 2025-04-01 | TXG | 0.05 | 1.38 | 11.98 |
| 2025-04-02 | TXG | 0.05 | 1.38 | 11.98 |
| 2025-04-03 | TXG | 0.05 | 1.38 | 11.98 |
| 2025-04-04 | TXG | 0.05 | 1.38 | 11.98 |
| 2025-04-07 | TXG | 0.05 | 1.36 | 11.98 |
| 2025-04-08 | TXG | 0.05 | 1.36 | 11.98 |
| 2025-04-09 | TXG | 0.05 | 1.36 | 11.98 |
| 2025-04-10 | TXG | 0.05 | 1.36 | 11.96 |
| 2025-04-11 | TXG | 0.05 | 1.36 | 11.96 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.4
Avg. EPS Est. Current Quarter
-0.29
Avg. EPS Est. Next Quarter
-0.14
Insider Transactions
0.05
Institutional Transactions
1.36
Beta
1.92
Average Sales Estimate Current Quarter
132
Average Sales Estimate Next Quarter
145
Fair Value
Quality Score
45
Growth Score
43
Sentiment Score
12
Actual DrawDown %
96.2
Max Drawdown 5-Year %
-96.5
Target Price
15.23
P/E
Forward P/E
PEG
P/S
1.6
P/B
1.38
P/Free Cash Flow
EPS
-1.52
Average EPS Est. Cur. Y
-0.54
EPS Next Y. (Est.)
-0.42
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-29.9
Relative Volume
1.08
Return on Equity vs Sector %
-45.3
Return on Equity vs Industry %
-40.7
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.08
EBIT Estimation
-41.9
10x Genomics, Inc.Sector: Healthcare
Industry: Health Information Services
Employees: 1306
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
stock quote shares TXG – 10x Genomics, Inc. Stock Price stock today
news today TXG – 10x Genomics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch TXG – 10x Genomics, Inc. yahoo finance google finance
stock history TXG – 10x Genomics, Inc. invest stock market
stock prices TXG premarket after hours
ticker TXG fair value insiders trading